Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria

Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine’s properties in terms of safety and efficacy both in allergic rhinitis and urticarioid...

Descripción completa

Detalles Bibliográficos
Autores principales: Nettis, E, Calogiuri, G F, Di Leo, E, Cardinale, F, Macchia, L, Ferrannini, A, Vacca, A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048603/
https://www.ncbi.nlm.nih.gov/pubmed/21437140
_version_ 1782199185951424512
author Nettis, E
Calogiuri, G F
Di Leo, E
Cardinale, F
Macchia, L
Ferrannini, A
Vacca, A
author_facet Nettis, E
Calogiuri, G F
Di Leo, E
Cardinale, F
Macchia, L
Ferrannini, A
Vacca, A
author_sort Nettis, E
collection PubMed
description Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine’s properties in terms of safety and efficacy both in allergic rhinitis and urticarioid syndromes.
format Text
id pubmed-3048603
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30486032011-03-23 Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria Nettis, E Calogiuri, G F Di Leo, E Cardinale, F Macchia, L Ferrannini, A Vacca, A J Asthma Allergy Review Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine’s properties in terms of safety and efficacy both in allergic rhinitis and urticarioid syndromes. Dove Medical Press 2008-12-16 /pmc/articles/PMC3048603/ /pubmed/21437140 Text en © 2009 Nettis et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Nettis, E
Calogiuri, G F
Di Leo, E
Cardinale, F
Macchia, L
Ferrannini, A
Vacca, A
Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
title Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
title_full Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
title_fullStr Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
title_full_unstemmed Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
title_short Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
title_sort once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048603/
https://www.ncbi.nlm.nih.gov/pubmed/21437140
work_keys_str_mv AT nettise oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria
AT calogiurigf oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria
AT dileoe oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria
AT cardinalef oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria
AT macchial oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria
AT ferranninia oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria
AT vaccaa oncedailylevocetirizineforthetreatmentofallergicrhinitisandchronicidiopathicurticaria

Ejemplares similares